loadpatents
name:-0.010897874832153
name:-0.011155843734741
name:-0.0051510334014893
Yates-Binder; Cecelia C. Patent Filings

Yates-Binder; Cecelia C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yates-Binder; Cecelia C..The latest application filed is for "small peptide compositions and uses thereof".

Company Profile
3.10.12
  • Yates-Binder; Cecelia C. - Pittsburgh PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Small Peptide Compositions And Uses Thereof
App 20220257718 - Yates-Binder; Cecelia C. ;   et al.
2022-08-18
Activators of CXCR3 for the treatment of angiopathies of the eye
Grant 11,406,687 - Wells , et al. August 9, 2
2022-08-09
Small peptide compositions and uses thereof
Grant 11,338,017 - Yates-Binder , et al. May 24, 2
2022-05-24
Activators Of Cxcr3 For The Treatment Of Angiopathies Of The Eye
App 20210000919 - Wells; Alan H. ;   et al.
2021-01-07
Goblet cell replacement therapy
Grant 10,561,710 - Yates-Binder , et al. Feb
2020-02-18
Small Peptide Compositions And Uses Thereof
App 20190298802 - Yates-Binder; Cecelia C. ;   et al.
2019-10-03
Goblet Cell Replacement Therapy
App 20180333460 - Yates-Binder; Cecelia C. ;   et al.
2018-11-22
Activators Of Cxcr3 For The Treatment Of Angiopathies Of The Eye
App 20180280478 - Wells; Alan H. ;   et al.
2018-10-04
Goblet cell replacement therapy
Grant 9,895,419 - Yates-Binder , et al. February 20, 2
2018-02-20
Activators of CXCR3 for the treatment of angiopathies of the eye
Grant 9,872,889 - Wells , et al. January 23, 2
2018-01-23
Goblet Cell Replacement Therapy
App 20170000852 - Yates-Binder; Cecelia C. ;   et al.
2017-01-05
Activators Of Cxcr3 For The Treatment Of Angiopathies Of The Eye
App 20160361387 - Wells; Alan H. ;   et al.
2016-12-15
Activators of CXCR3 for the treatment of angiopathies of the eye
Grant 9,452,200 - Wells , et al. September 27, 2
2016-09-27
Activators Of Cxcr3 For The Treatment Of Angiopathies Of The Eye
App 20160022779 - Wells; Alan H. ;   et al.
2016-01-28
Activators of CXCR3 for the treatment of angiopathies of the eye
Grant 9,180,167 - Wells , et al. November 10, 2
2015-11-10
Activators Of Cxcr3 For The Treatment Of Angiopathies Of The Eye
App 20140178451 - Wells; Alan H. ;   et al.
2014-06-26
Chemokine derived peptides that bind with chemokine receptor CXCR3 and uses for chronic wound and angiogenesis inhibition treatments
Grant 8,734,775 - Yates-Binder , et al. May 27, 2
2014-05-27
Chemokine Derived Peptides And Uses For Chronic Wound And Angiogenesis Inhibition Treatments
App 20130053319 - Yates-Binder; Cecelia C. ;   et al.
2013-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed